Ethzilla CORP (FRMM) — 10-Q Filings

All 10-Q filings from Ethzilla CORP. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (5)

ETHZilla Pivots to Crypto, Reports Massive Loss Amid Fundraising Spree — Nov 14, 2025 Risk: high
ETHZilla Corp (FRMM) reported a significant strategic shift and substantial financial changes for the nine months ended September 30, 2025. The company generate
180 Life Sciences Posts No Revenue, Focuses on Clinical Trials — Jul 23, 2025 Risk: high
180 Life Sciences Corp. (FRMM) reported no revenue for the quarter ended June 30, 2025, consistent with its status as a clinical-stage biotechnology company. Th
180 Life Sciences Corp. Files Q1 2025 10-Q — May 15, 2025 Risk: low
180 Life Sciences Corp. filed its quarterly report (10-Q) for the period ending March 31, 2025. The company, formerly known as KBL Merger Corp. IV, is incorpora
180 Life Sciences Corp. Files Q3 2024 10-Q Report — Nov 14, 2024 Risk: low
180 Life Sciences Corp. filed its quarterly report (10-Q) for the period ending September 30, 2024. The company, formerly known as KBL Merger Corp. IV, is incor
180 Life Sciences Corp. Files Q2 2024 10-Q Report — Aug 12, 2024 Risk: low
180 Life Sciences Corp. filed its quarterly report on Form 10-Q for the period ended June 30, 2024. The company, formerly known as KBL Merger Corp. IV, is incor

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX